第1個想到的是,快50了,太可怕了。
如果65歲退休,還可以奮鬥20年,但是知道自己的潛力有限了。
如果未來幾年,沒有好的學生或合作同伴,我的墓誌銘早已定稿。
從2009年7月生涯第1次研究休假開始撰寫 blog,以跟同學、好友交流教學/研究,甚至臨床之心得。
以下是我的座右銘:
Try hard enough, you can get what you want!
Talent is the desire to practice.
Slow and Steady wins the game.
Better to light one candle than to curse the darkness.
你現在的努力 要感動未來的你!
只有藉由他人的視野,才能看到自己思考上的盲點。
2009年10月19日 星期一
2009年10月18日 星期日
2009年10月16日 星期五
A meeting with Louise for her plan
She is interested in revising the CHEDOKE (measuring bilateral hand function). The CHEDOKE's developer Sussan will come to Brisbane in the end of October.
I recommend her to ask for Susan's data sets for her revisions.
She's also interested in my datat sets about UE logitudinal follow-up data. I'll send her papers for what I have done on the data set.
I recommend her to ask for Susan's data sets for her revisions.
She's also interested in my datat sets about UE logitudinal follow-up data. I'll send her papers for what I have done on the data set.
2009年10月14日 星期三
The impact of my current and future study
To address Jake's question about whether my studies are big, I may address such an issue on several perspectives 1. the impact of my studies, 2. whether the results can be accumulated.
To be continued...
To be continued...
2009年10月13日 星期二
2009年10月9日 星期五
The meeting with Tammy & Sally
The psychometric properties of the Stroke Knowledge Questionnaire was modest in terms of reliability and responsivess. They seem to revise the questionnaire in the future.
The validity of the questionnaire is largely unknown. Thus, I'll perform CFA and IRT to determine it's construct validity.
The current examination of the self-efficacy VAS is limited becuase of weak theoretical framework. In addition, test-retest reliability is needed. So we'll leave it here until they have criteria to compare and/or test-retest data.
In addition, I might have to tell them that I'm developing an item bank for stroke knowledge in the near future.
The validity of the questionnaire is largely unknown. Thus, I'll perform CFA and IRT to determine it's construct validity.
The current examination of the self-efficacy VAS is limited becuase of weak theoretical framework. In addition, test-retest reliability is needed. So we'll leave it here until they have criteria to compare and/or test-retest data.
In addition, I might have to tell them that I'm developing an item bank for stroke knowledge in the near future.
2009年9月29日 星期二
A meeting with Tammy & Sally
They developed 2 questionnaires (stroke knowledge & self-efficacy). My preliminary data analyses found that both questionnaires have some limitations (e.g. small to moderate responsiveness, weak theoretical basis). However, they don't make decision to revise both questionnaires. It's hard for researchers interested in clinical trials.
訂閱:
文章 (Atom)